Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC).

Details

Request a copyRequest a copy
Serval ID
serval:BIB_5CB69D973D69
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Efficacy, safety, and biomarker results of trastuzumab emtansine (T-DM1) in patients (pts) with previously treated HER2-overexpressing locally advanced or metastatic non-small cell lung cancer (mNSCLC).
Journal
Journal of Clinical Oncology
Author(s)
Stinchcombe Tom, Stahel Rolf A., Bubendorf Lukas, Bonomi Philip, Villegas Augusto E., Kowalski Dariusz, Baik Christina S., Isla Dolores, De Castro Javier, Garrido Lopez Pilar, Rittmeyer Achim, Tiseo Marcello, Stanzel Sven Franz, de Haas Sanne, Lam Lisa, Lu Michael, Peters Solange
ISSN
0732-183X
1527-7755
Publication state
Published
Issued date
20/05/2017
Volume
35
Number
15_suppl
Pages
8509-8509
Language
english
Keywords
Cancer Research, Oncology
OAI-PMH
oai:serval.unil.ch:BIB_5CB69D973D69
DOI
10.1200/jco.2017.35.15_suppl.8509
Web of science
000411932202059
Create date
28/11/2023 11:17
Last modification date
29/11/2023 7:12
Usage data